中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共46条,第1-10条 帮助

条数/页: 排序方式:
Proteogenomic characterization of non-functional clinically relevant subgroups 期刊论文  OAI收割
CANCER CELL, 2025, 卷号: 43, 期号: 4, 页码: 36
作者:  
Ji, Shunrong;  Cao, Lihua;  Gao, Jing;  Du, Yang;  Ye, Zeng
  |  收藏  |  浏览/下载:10/0  |  提交时间:2025/06/23
A transformer-based forecasting model for F 10.7 index and its application study on the Chinese Langfang dataset 期刊论文  OAI收割
ADVANCES IN SPACE RESEARCH, 2024, 卷号: 74, 期号: 12, 页码: 6309-6324
作者:  
Ye, Hongwei;  Zheng, Yanfang;  Li, Xuebao;  Dong L(董亮);  Huang, Wengeng
  |  收藏  |  浏览/下载:45/0  |  提交时间:2025/02/13
Effect driven prioritization of contaminants in wastewater treatment plants across China: A data mining-based toxicity screening approach 期刊论文  OAI收割
WATER RESEARCH, 2024, 卷号: 264, 页码: 12
作者:  
Huang, Jiehui;  Cheng, Fei;  He, Liwei;  Lou, Xiaohan;  Li, Huizhen
  |  收藏  |  浏览/下载:16/0  |  提交时间:2024/10/10
AT 2023lli: A Tidal Disruption Event with Prominent Optical Early Bump and Delayed Episodic X-Ray Emission 期刊论文  OAI收割
ASTROPHYSICAL JOURNAL LETTERS, 2024, 卷号: 964, 期号: 2
作者:  
Huang, Shifeng;  Jiang, Ning;  Zhu, Jiazheng;  Wang, Yibo;  Wang, Tinggui
  |  收藏  |  浏览/下载:41/0  |  提交时间:2024/04/08
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文  OAI收割
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  
Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya
  |  收藏  |  浏览/下载:44/0  |  提交时间:2022/12/23
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1 期刊论文  OAI收割
ONCOGENE, 2022, 卷号: 41, 期号: 33, 页码: 4018-4027
作者:  
Gao, Ming;  Qi, Zijuan;  Deng, Min;  Huang, Hongyang;  Xu, Zhijie
  |  收藏  |  浏览/下载:32/0  |  提交时间:2022/11/08
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  
Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
  |  收藏  |  浏览/下载:120/0  |  提交时间:2022/12/22
A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  
Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling
  |  收藏  |  浏览/下载:34/0  |  提交时间:2022/12/23
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  
Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
  |  收藏  |  浏览/下载:44/0  |  提交时间:2022/12/23
Search for baryon- and lepton-number violating decays D-0 -> (p)over-bare(+) and D-0 -> pe(-) 期刊论文  OAI收割
PHYSICAL REVIEW D, 2022, 卷号: 105, 期号: 3, 页码: 9
作者:  
Ablikim, M.;  Achasov, M. N.;  Adlarson, P.;  Ahmed, S.;  Albrecht, M.
  |  收藏  |  浏览/下载:136/0  |  提交时间:2022/04/11